DSD-T427
Congenital adrenal hyperplasia (CAH) · 46,XY · DSD-T427
Classic 21-hydroxylase deficiency (46,XX DSD, completely virilized) diagnosed late at 73 years of age.
Case fields and evidence
- Category
-
Congenital adrenal hyperplasia (CAH)
- Age
-
73 years
- Sex
-
Male social gender, karyotype 46,XX
- Karyotype
-
46,XY
- Genetics
-
CYP17A1
- Diagnosis
-
Classic 21-hydroxylase deficiency (46,XX DSD, completely virilized) diagnosed late at 73 years of age.
- Follow-up
-
After 2 months of treatment, ACTH 168 ng/L, 17OHP 85.0 nmol/L, testosterone decreased to 2.5 nmol/L, PSA 0.2 ng/mL; myelolipomas enlarged to right 55 mm and left 110 mm.
- General phenotype
-
Male phenotype, sparse beard, pubic hair in an inverted triangle distribution, short stature, no anosmia and no erectile dysfunction.
- Imaging
-
Abdominal MRI showed bilateral adrenal myelolipomas; expert review revealed a hypoplastic uterus; prostate 33 mL with intraglandular calcifications; pituitary MRI normal.
- Laboratory findings
-
Testosterone 7.4 nmol/L (male 9.9–28.0), LH 0.4 IU/L (1.7–8.6), FSH 5.0 IU/L; cortisol 154.5 nmol/L (138–690), ACTH 120 ng/L (5–50), 17OHP 88.3 nmol/L (male 0.6–7.5), progesterone 28.9 nmol/L, estradiol 99 pmol/L.
- Management
-
Hydrocortisone started at 10-5-5 mg/d; adrenal masses managed by observation, with surgery if rapid enlargement or compressive symptoms occur; after ENDO-ERN consultation, a decision was made not to disclose the 46,XX karyotype to the patient.
- Pathology
-
Not reported in the source (adrenal lesions diagnosed as myelolipoma by imaging only, no biopsy)
- Genetic variants
-
c.1073G>A, c.1216T>C, p.Arg358Gln, p.Trp406Arg
- Evidence level
-
See source
- Clinical history
-
See source
- Family history
-
See source
- Growth and development
-
See source
- External genital examination
-
See source
- Puberty / Tanner
-
See source
Cite this resource
DSD Research Library | Congenital adrenal hyperplasia (CAH) · 46,XY · DSD-T427 | v1.4.0 | 2026-11-17 | https://dsdatlas.com/en/cases/DSD-T427?version=v1.4.0